Business
Voyageur Pharmaceuticals & Summit Nanotech Corporation Sign Memorandum of Understanding for a Technology Development Project
(TheNewswire) Calgary, Alberta - TheNewswire - November 8 , 2021 ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals & Summit Nanotech Corporation Sign Memorandum of Understanding for a Technology Development Project\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire -\n \n \n November 8\n \n \n , 2021 -\n \n \n Voyageur Pharmaceuticals Ltd.\n \n \n (TSXV:VM)\n \n \n (\n \n \n OTC\n \n \n :\n \n \n \n VYYRF)\n \n \n \n (the\n\"Company\" or \"Voyageur\") is pleased to announce\nthe signing  of a non-binding\n \n \n Memorandum of\n Understanding (“MOU”)\n \n \n with\n \n \n Summit Nanotech Corporation (“SNT”).\n \n \n The MOU proposes an agreement between Voyageur\nand SNT to develop a more sustainable process for the production of\niodine medical products, that are used as contrast agents. The process\nwill be developed by leveraging SNT’s award winning lithium\nextraction technology.\n \n \n \n \n There have been no significant advancements in\nprocessing technology in over 20 years in the compounding of iodine\nmedical products. SNT’s innovative nanomaterials have the potential\nto decrease production costs and increase production efficiency, while\nalso creating a lower environmental footprint. By collaborating with\nSNT and operating a “green” pharmaceutical manufacturing process,\nVoyageur will contribute to a reduction in worldwide carbon emissions\nand ensure that their long-term goals align with the United Nations\nAgenda 2030 Sustainable Development Plan.\n \n \n \n \n Brent Willis, CEO of Voyageur states, “By joining\nwith SNT, we are fortifying our concept of fully integrating our\noperations from earth to bottle. Manufacturing contrast agents that we\ncontrol at costs that are lower than those of other iodine producers,\nwill enable Voyageur to gain a competitive edge in the marketplace and\nhelp to reduce healthcare costs worldwide.”\n \n \n \n \n Amanda Hall, CEO of Summit Nanotech states,\n“Voyageur’s holistic approach of\n \n \n mineral\nextraction from\n \n \n underground brines for iodine,\nusing sustainable processes, aligns with Summit’s existing asset\ndevelopment strategy. By creating new nanomaterials to isolate iodine\nin tandem with lithium, we are cutting emissions, reducing waste and\nfurther contributing to the circular economy.”\n \n \n \n \n About S...